Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

I

Izmir City Hospital

Academic

0

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

0

Indications↗

Distinct diseases across all programs

9

Clinical Trials↗

All sponsored trials (all statuses)

Activity

Recent Activity

Last 14 days

Evaluation of the Relationship Between the Presence of Post-Stroke Ideomotor Apraxia and Motor Function, Balance, and Gait Parameters

Effect of Ideomotor Apraxia on the Outcomes of Robotic Gait Rehabilitation in Patients With Stroke: A Prospective Observational Study

Tracheostomy Practices in Adult Intensive Care Units in Izmir, Turkey: A Multicenter Point-Prevalence Study

Earlier

Oct 15, 2026TrialEfficacy of Tecar Therapy Versus Conventional Physical Therapy and Sham Treatment in Patients With Lumbar Radiculopathy: A Randomized Controlled Trial

Oct 9, 2026TrialEffects of Repeated Electroconvulsive Therapy on Anesthetic Requirements: A Prospective Observational Study

Oct 2, 2026TrialThe Relationship of Quadriceps Muscle Echogenicity and Thickness Change During Isometric Contraction With Pain, Function, Quality of Life, and Patient Global Assessment in Knee Osteoarthritis

Sep 1, 2026TrialEvaluation of the Effect of Trendelenburg Position on Upper Airway Edema by Ultrasonography and Its Relationship With Postoperative Clinical Airway Findings in Patients Undergoing Laparoscopic Hysterectomy

Aug 15, 2026TrialAnalgesic Efficacy of the Shoulder Posterior Pericapsular Nerve Group Block Versus Combined Posterior Suprascapular and Axillary Nerve Blocks for Shoulder Arthroscopy: A Randomized, Blinded, Non-Inferiority Trial

1 more events

Jul 15, 2026TrialThe Effect of Live Video Parent-Child Interaction and Cartoon Watching on Emergence Agitation in Children Aged 2-6 Years: A Randomized Controlled Trial

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)